Close

content

NINLAROTM Receives Conditional Approval from the European Commission to Treat Multiple Myeloma

Takeda Pharmaceutical Company Limited announced that the EC has granted conditional marketing authorization for NINLAROTM (ixazomib)capsules, indicated in combination with lenalidomide and dexamethasone for...

Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial

Eli Lilly and Company announced that solanezumab did not meet the primary endpoint in the EXPEDITION3 clinical trial, a phase 3 study of solanezumab...

Sun Pharma to acquire Biosintez in Russia 

Sun Pharma announced the execution of definitive agreements by its wholly owned subsidiary, for the acquisition of 85.1% of JSC Biosintez, a Russian pharmaceutical...

Hikma announces agreement with Vectura for the development of generic salmeterol for the US market

Hikma Pharmaceuticals PLC the fast growing multinational pharmaceutical group, announces that it has, through its wholly owned US subsidiary West-Ward Pharmaceuticals, signed a development...

Pharma Industry was helped by SCHOTT to give the Right Prefilled Syringe

At the Pharmtech 2016 trade show SCHOTT experts will encourage visitors to take a holistic approach to find the best solution. “Consulting pharma companies...

Novartis acquires Selexys Pharmaceuticals Corporation and SelG1 antibody for reduction of pain crises in sickle cell disease (SCD)

Novartis announced it has acquired Selexys Pharmaceuticals Corporation, a company specializing in development of therapeutics in certain hematologic and inflammatory disorders. ...

Landmark celebration of the Indian Pharma Industry as the 10th edition of CPhI & P-MEC India gets underway

The Indian pharmaceutical industry saw the launch of the grand 10th anniversary edition of UBM India’s signature event, CPhI & P-MEC India 2016, one...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read